Table 5 Comparison of treatment data between lupus nephritis patients with and without renal TMA
From: The spectrum of renal thrombotic microangiopathy in lupus nephritis
| Â | LN with renal TMA | LN without renal TMA | P-value |
|---|---|---|---|
Number of patients (%) | 36 | 112 | Â |
Treatment | Â | Â | Â |
PE (Number of patients (%)) | 19 (52.8) | 7 (6.25) | <0.001 |
MP (Number of patients (%)) | 26 (72.2) | 18 (16.1) | <0.001 |
P | 36 (100) | 112 (100) | 1 |
CYC | 30 (83.3) | 88 (78.6) | 0.536 |
AZA | 1 (2.8) | 5 (4.5) | 1 |
MMF | 3 (83.3) | 11 (9.8) | 1 |
LEF | 2 (5.6) | 8 (7.1) | 1 |
Treatment response | Â | Â | Â |
CR | 8 (22.2) | 30 (26.8) | 0.586 |
PR | 12 (33.3) | 65 (58.0) | 0.01 |
TF | 16 (44.4) | 17 (15.2) | <0.001 |
Duration of follow-up (m) | 53 (6,240) | 53 (6,282) | 0.15 |
Relapse rate | 4 (4/20, 20%, 3 with nephritic relapse and 1 with proteinuric relapse) | 17 (17/95, 17.89%, 15 with nephritic relapse and 2 with proteinuric relapse) | 0.543 |